|
Volumn 14, Issue 3, 2002, Pages 260-264
|
Testicular cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIEMETIC AGENT;
BLEOMYCIN;
CARBOPLATIN;
CISPLATIN;
CORTICOSTEROID;
DEXAMETHASONE;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ETOPOSIDE;
LACTATE DEHYDROGENASE ISOENZYME;
SEROTONIN ANTAGONIST;
TUMOR MARKER;
CANCER CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER SURGERY;
CANCER SURVIVAL;
CHEMOTHERAPY INDUCED EMESIS;
CHROMOSOME 12P;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DIAGNOSTIC IMAGING;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG RETENTION;
GENE EXPRESSION;
GERM CELL TUMOR;
HUMAN;
ISOCHROMOSOME;
MALE;
MALE FERTILITY;
MOLECULAR GENETICS;
NON SEMINOMATOUS GERMINOMA;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RADIATION CARCINOGENESIS;
REVIEW;
RISK FACTOR;
SEMINOMA;
SOLID TUMOR;
TESTIS CANCER;
THROMBOEMBOLISM;
ANTINEOPLASTIC AGENTS;
HUMANS;
MALE;
QUALITY OF LIFE;
RISK FACTORS;
TESTICULAR NEOPLASMS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0036254843
PISSN: 10408746
EISSN: None
Source Type: Journal
DOI: 10.1097/00001622-200205000-00002 Document Type: Review |
Times cited : (8)
|
References (31)
|